Specialty Medicines
Teva Pharmaceutical Industries (NYSE:TEVA) - Share price, News & Analysis - Simply Wall St
Teva Pharmaceuticals – Walk-In Interviews on 18th Dec' 2021 - Pharmaceutical Guidance
New York takes Teva, McKesson, others to trial over opioids | Business Insurance
Teva specialty medicine revenue by product 2018-2021 | Statista
Teva Pharmaceuticals (@TevaUSA) / Twitter
PharmaBoardroom - TEVA
The Teva-Allergan deal shows why pharma mergers are booming | Fortune
Israel's Teva gets green light from China on major treatment - www.israelhayom.com
Generic medicines
Teva Wins US Nod for Allergan's Generics | CHEManager
Complex generics will boost speciality biz, Teva says
Teva Pharmaceutical CEO says health-care is facing 'huge disruption'
Teva sells Paragard to CooperSurgical for $1.1B - Philadelphia Business Journal
Teva Pharmaceutical Industries
Transitioning Teva revamps branding to emphasize brand-generic unity | Fierce Pharma
Specialty Medicines
Teva's Respiratory Drugs Contribute 11% to Specialty Medicines
Central Nervous System Is Key to Teva's Specialty Medicines
Teva Pharmaceuticals forms global specialty medicines group - Philadelphia Business Journal
Teva Generic Medicines Saved the United States $28.8 Billion in 2020, and a Total of $43.1 Billion Across Major Markets, According to Independent Analysis | Business Wire
Teva Walks Away from Negotiations Over Healthcare Fraud Charges
Company Facts & Figures
Insights on Teva's acquisition of Allergan Generics | Packaging World
